Evaluation of hyperprogression in patients with sarcoma treated with targeted therapy and/or immunotherapy in early-phase clinical trials. HH2853, an EZH1/2 inhibitor, in patients with epithelioid ...

Investigators from Germany conducted a systematic review of different MRI features in soft tissue sarcoma (STS) that are used to infer tumor histological grade. Those 6 characteristics are tumor size, ...

Patients in this analysis were treated between 2007 and 2020 and could have received radiotherapy either before or after surgery for soft tissue sarcoma (STS). STS is rare, in that it accounts for a ...

Extraskeletal osteosarcoma is a rare and aggressive malignant tumour arising in soft tissues, distinguished by its production of osteoid without any direct attachment to the skeleton. Although it ...

A soft tissue sarcoma (STS) is a malignant tumor that starts in soft tissue such as muscle, deep skin tissues, cartilage, or fat. It often occurs as a lump in the arm, although it can happen anywhere.

Patients with non-metastatic soft tissue sarcoma (STS) who need pre-operative radiation therapy can safely receive hypofractionated treatment over three weeks instead of five, with comparable tumor ...

Soft tissue sarcoma (STS) is a rare type of cancer that can quietly grow in the connective tissues of the body—such as fat, muscles, nerves, blood vessels, or beneath the skin. Although it represents ...

NRG Oncology (NRG), a National Cancer Institute (NCI) National Clinical Trials Network (NCTN) group focused on improving outcomes for adults with cancer through multi-center clinical research, ...